Significance
Cancer cells undergo dramatic metabolic alterations, such as the Warburg effect where glucose is consumed independently of oxygen, leading to high lactic acid production. Although these alterations can give growth advantages to cancer cells, they have a profound effect in the extracellular environment, and thus it is not clear how they affect healthy cells. Here we show that lactic acid accumulation can impair the survival of tumor-associated macrophages. Using a multidisciplinary combination of computational and experimental methods, we show that this decreased survival can lead to spatial patterns of macrophage localization that resemble how tumor-associated macrophages distribute in real tumors. Spatial patterns can potentiate tumor growth, and thus understanding how they are formed may bring therapeutic insights.
Keywords: tumor adaptation, mathematical model, image analysis
Abstract
Drastic metabolic alterations, such as the Warburg effect, are found in most if not all types of malignant tumors. Emerging evidence shows that cancer cells benefit from these alterations, but little is known about how they affect noncancerous stromal cells within the tumor microenvironment. Here we show that cancer cells are better adapted to metabolic changes in the microenvironment, leading to the emergence of spatial structure. A clear example of tumor spatial structure is the localization of tumor-associated macrophages (TAMs), one of the most common stromal cell types found in tumors. TAMs are enriched in well-perfused areas, such as perivascular and cortical regions, where they are known to potentiate tumor growth and invasion. However, the mechanisms of TAM localization are not completely understood. Computational modeling predicts that gradients—of nutrients, gases, and metabolic by-products such as lactate—emerge due to altered cell metabolism within poorly perfused tumors, creating ischemic regions of the tumor microenvironment where TAMs struggle to survive. We tested our modeling prediction in a coculture system that mimics the tumor microenvironment. Using this experimental approach, we showed that a combination of metabolite gradients and differential sensitivity to lactic acid is sufficient for the emergence of macrophage localization patterns in vitro. This suggests that cancer metabolic changes create a microenvironment where tumor cells thrive over other cells. Understanding differences in tumor-stroma sensitivity to these alterations may open therapeutic avenues against cancer.
Cancer cells in tumors display pronounced metabolic alterations (1–10). The genetic and biochemical mechanisms behind these changes are under intensive investigation, but the question of how metabolic changes affect noncancerous cells in the tumor microenvironment remains largely unanswered. The Warburg effect—or oxidative glycolysis, a process whereby cells exhibit a high glycolytic rate even in the presence of oxygen—is arguably the best-known metabolic alteration in cancer (1). Due to a lower yield of glucose to ATP associated with glycolysis, the Warburg effect was initially viewed as a detrimental aberration (1, 5). However, it is now clear that ATP is not a limiting resource for cell growth (4, 9) and that glycolytic alterations increase glucose and glutamine uptake, enhance reductive power, and favor anabolism by retaining carbon-rich macromolecules (4, 7, 9). Thus, rather than being detrimental, metabolic alterations in tumor cells can be required to sustain the high proliferation rate that characterizes malignant cancers (4, 7, 9). In fact, similar metabolic changes occur in healthy processes with rapid population growth such as pluripotent stem-cell proliferation (11), T-cell activation (12), embryonic development (13), and wound healing (14), suggesting that cancer cells have co-opted conserved metabolic processes used by rapidly proliferating cells (4, 7, 9).
Despite their beneficial effect for cell proliferation, metabolic changes have dramatic consequences on the extracellular milieu. Alterations in tumor metabolism were first identified by studying how cancer cells alter their culture media (1, 5). Chaotic vascularization can be a feature in tumors in vivo, which intensifies the effect of cancer cells on their microenvironment and causes damaging processes such as acidosis, hypoxia, and nutrient deprivation (15, 16). Thus, cancer cells must balance the benefits of an altered metabolism with its potentially toxic extracellular consequences.
Cancer is a disease of clonal evolution where different cell lineages compete (17, 18). Mathematical models in the literature suggest that metabolic modifications can be advantageous for lineages competing within tumors (16, 19–21). Nonetheless, how stromal cells within tumors cope with these changes has been largely neglected. Thus, it is possible that a toxic microenvironment created by metabolic alterations may be a mechanism for cancer cells to gain a selective advantage.
We focused our study on how tumor metabolism affects macrophages. Tumor-associated macrophages (TAMs) are one of the most common stromal cell types found within tumors, and their number is directly correlated with poor patient prognosis in the majority of cancers analyzed to date (22–26). TAMs are well adapted to, and recruited toward, low-oxygen-tension regions (22, 27, 28). However, TAMs in vivo are also enriched in well-perfused regions of the tumor—such as the invasive edge and perivascular areas—where they potentiate cancer progression and invasion (29–31). Other tumor-associated stromal cells, live, or even dying cancer cells are known to recruit macrophages to the tumor (32–34). Nonetheless, why resident and recruited macrophages do not infiltrate the tumor homogenously remains poorly understood. An intriguing hypothesis then is that TAMs may be precluded from poorly perfused regions because metabolic alterations generate a toxic environment where only adapted tumor cells can survive.
Here we show that metabolically altered microenvironments can indeed provide cancer cells with a selective advantage. In particular, these cancer cells are more resistant than macrophages to high levels of lactic acid produced by their glycolytic metabolism. We combine computational modeling with a custom-made cell culture system that allows the emergence of spatially graded microenvironments ranging from well-perfused to ischemic regions. With this approach we show that differential sensitivity to lactic acid between cancer cells and macrophages is sufficient to generate localization patterns that resemble in vivo observations.
Results
Glycolytic Cancer Cells Are Adapted to Lactic Acid.
We first investigated the impact of the metabolic activity of cancer and stromal cells on their surrounding microenvironment. We used primary bone marrow-derived macrophages (BMDMs) as our model for stromal cells and MTLn3 cells, an aggressive metastatic breast adenocarcinoma line widely used in tumor-stromal studies (35), as a model cancer cell line. When grown for 24 h, MTLn3 cells, but not macrophages, significantly increased lactate levels and decreased glucose levels in the culture media even in the presence of oxygen, evidencing enhanced oxidative glycolysis [Fig. 1A; note that these trends are maintained when metabolites levels are normalized by total biomass (SI Appendix, Fig. S1A)]. In addition, MTLn3 cancer cells showed higher glutamine consumption, as has been reported for other cancer cells (36), whereas other measured metabolites were not substantially changed (SI Appendix, Fig. S1A). We confirmed these observations by measuring glucose consumption and lactate production in a panel of cancerous and noncancerous cells. All tested cancer cells showed a similar behavior to MTLn3, whereas low passage, nontransformed, mouse embryonic fibroblasts (MEFs) behaved similarly to macrophages (SI Appendix, Fig. S1B). These data confirm that at least a panel of cancer cells, but not stromal cells, display typical metabolic alterations such as the Warburg effect.
Next, we examined how MTLn3 cells and macrophages adapt to nutrient depletion. We examined the role of starvation by culturing cells for 24 or 48 h under a range of nutrient compositions and measuring cell viability. Most viability methods rely on measuring activity of metabolic enzymes at a population level, which may be altered by nutrient limitation and produce experimental biases. We circumvented this limitation by adding a fluorescent dye that is incorporated only by cells with compromised cell membranes. This allowed us to measure viability at the single-cell level using microscopy and image analysis (SI Appendix). Starvation by the withdrawal of glucose, glutamine, or serum did not have a significantly different effect on the survival of either cell type (SI Appendix, Fig. S2A). Likewise, hypoxia, i.e., oxygen starvation alone or combined with different nutrient deprivations, did not induce notable differential changes in the viability of the cells (SI Appendix, Fig. S2A). The observation that macrophages remain viable under oxygen deprivation is consistent with reports of macrophages being recruited to anoxic and necrotic regions of tumors (28) and the observation that macrophages survive and adapt well to hypoxia (27). In summary, nutrient deprivation and hypoxia appear to affect MTLn3 cells and macrophages equivalently.
Next we investigated the effect of lactate on cell viability, because its secretion levels are remarkably different among tested cancerous and noncancerous cell lines. Adding lactic acid to the growth media showed that, although extremely high levels of lactic acid are lethal for both MTLn3 and macrophages, MTLn3 cells survive better than macrophages at intermediate levels (∼25–30 mM; Fig. 1B). These levels of lactic acid are close to the ones produced by MTLn3 cells (Fig. 1A) and to those reported in human tumors (37, 38). Control experiments carried out using sodium lactate instead of lactic acid did not show a significant difference in survival, suggesting that the detrimental effect of lactic acid to macrophages is through media acidification (SI Appendix, Fig. S2B). Additional experiments with our cell panel using lactic acid confirmed that cancerous cell lines tend to be more resistance to lactic acid than macrophages and MEFs (SI Appendix, Fig. S2C). Furthermore, MTLn3 cells are also more resistant than macrophages to acetic acid, supporting the role of pH in cell viability (SI Appendix, Fig. S2D).
To evaluate whether this differential effect still occurs when the two cell types share the same microenvironment, we cocultured MTLn3 and macrophages at a range of lactic acid concentrations and measured the relative contribution of each cell type to the final population after 24 h. Lactic acid specifically reduced the proportion of macrophages in the coculture population (Fig. 1C), confirming that MTLn3 cells are fitter when lactic acid accumulates. This effect can be reverted by the addition of bicarbonate to the media, further confirming the role of pH (SI Appendix, Fig. S3 C and D).
Model Reveals That Restricted Perfusion Generates Metabolic Gradients and Spatial Structure in Cell Populations.
TAMs in vivo are enriched in well-perfused regions of large tumors such as in perivascular regions and at the invasive edge (Fig. 2A and SI Appendix, Fig. S4). However, in small tumors TAMs are usually dispersed throughout the tumor mass (30) (SI Appendix, Fig. S4). The differential sensitivity shown in our experiments suggests that macrophages may not survive in conditions of high lactic acid concentration, which is more likely to occur in larger, poorly perfused, tumors (16). We therefore asked whether the accumulation of lactic acid in poorly perfused regions is sufficient to explain the localization patterns of macrophages. Computational models have shown that glycolysis would lead to lactate gradients due to increased secretion and to steep drops in pH (16, 19), but the effect of these gradients on stromal cells remains unexplored. Thus, we created a computational model where a mixed population of tumor cells and macrophages coexist in a confined space representing tissue adjacent to a blood capillary or at the tumor edge next to normal tissue (Fig. 2B). In this model, cells consume resources (e.g., glucose and oxygen, denoted as “R” in Fig. 2B) at rate q and secrete metabolic waste products (such as lactic acid, denoted as “W” in Fig. 2B) at rate k. Resources diffuse into the system from one side (with diffusivity DR). Similarly, waste is cleared via the same side with diffusivity DW. In our experiments, cancer cells and macrophages are equally resistant to starvation and hypoxia (SI Appendix, Fig. S2A), but macrophages are more sensitive to lactic acid levels (Fig. 1 B and C). Because lactic acid production increases in low oxygen (Fig. 1A), hypoxia could lead to macrophage death indirectly due to lactic acid accumulation. Thus, in our model the levels of waste (lactic acid) are a function of resource (oxygen) depletion (SI Appendix, Table S1).
Solving the model analytically gives the expected decreasing curve for R and increasing levels of W (Fig. 2C). Using this model, and incorporating biophysically relevant parameters (SI Appendix, Table S2), we simulated the evolution of a cell coculture using an agent-based computational approach. We adopted an established off-lattice agent-based modeling (ABM) framework used to model other complex multicell systems such as bacterial biofilms (39, 40). Similar approaches have been used to model tumor growth (20, 41). In this ABM framework, cells are modeled as discrete agents with rules that mimic the behavior of cells (growth, division, death, etc.), whereas gradients of metabolites are modeled using continuum partial differential equations (SI Appendix) (39). Under these conditions, the simulated cancer cells and macrophages coexist in well-perfused regions, but only cancer cells are able to survive in ischemic regions (Fig. 2D, “Tumor”; SI Appendix, Movie S1). In contrast, when we conduct the simulations making oxygen 10 times more diffusive to increase perfusion, the spatial structure is lost (Fig. 2D, “Control”; SI Appendix, Movie S1). Thus, spatial structure can be an emergent property if cells have different sensitivities to microenvironmental conditions when perfusion is poor. Importantly, in our simulations, spatial heterogeneities are not externally imposed but are the result of diffusion and reaction processes. Similar models have been used to explain the formation of necrotic cores (42) or the evolution of more aggressive tumor clones (16, 19, 20). Here, our model shows that self-generated gradients can play an important role in the spatial distribution of cancer cells and tumor-associated macrophages resembling in vivo observations.
Experimental Validation with a Tissue Mimetic System.
Computational model predictions can be compared with in vivo data, such as imaging (43, 44), but models are difficult to test experimentally. In vivo manipulations are technically challenging and in vitro models often neglect important features such as spatial structure. To circumvent these limitations, we adapted a tissue-mimetic culture system (45) to mimic the tumor microenvironment in vitro. This setup allows coculture of different cell types and the spontaneous formation of gradients while still permitting direct cell imaging (Fig. 3A and SI Appendix). Briefly, cells are cultured in a small volume (in the ∼50-μL internal chamber) that is connected to a larger volume (the ∼2-mL external chamber) through a small slit or opening (∼0.3 mm wide). The external chamber thus constitutes a bulk source of nutrients and provides a sink of waste products, creating a directional gradient of any diffusible substances consumed or produced by cells in the internal chamber. The self-generated gradients in this simple setup ensure that cells proximal to the slit will be well perfused, whereas cells distal to the slit will be progressively more ischemic (Fig. 3A). The cell population cultured in the interior chamber is imaged using a programmable motorized microscope stage and tiled microscopy to build large-scale mosaics of adjacent pictures, producing images that combine high resolution with a wide field of view. Thus, we can investigate cell populations at multiple scales from the single-cell to multicellular level simultaneously (Fig. 3 A and B; SI Appendix, Fig. S5A).
We first confirmed that our system allows the spontaneous formation of metabolite gradients. We used a glioma cell line (C6-HRE-GFP) that expresses GFP under hypoxic conditions (46) as a reporter for oxygen limitation. We used two experimental controls. First, we produced a similar culture system but without the separation between the two chambers. Under these conditions, diffusible substances can diffuse freely to and from the bulk above the cells, and therefore no horizontal gradients should be formed. Second, we modified our graded assay by separating the two chambers with a gas-permeable membrane of olydimethylsiloxane (PDMS). In this setting, certain diffusibles such as glucose and lactate will not permeate through the membrane. However, oxygen and other gases can diffuse freely (47). As expected, no GFP was detected in either of the control settings, and cells maintained their viability, confirming that oxygen permeates PDMS freely. In contrast, in the glass-separated chamber, GFP levels increased significantly in a manner dependent on the distance from the slit, showing evidence of oxygen limitation (Fig. 3C and SI Appendix, Fig. S5B). Hence, our system allows the spontaneous formation of oxygen gradients due to its diffusion into the internal chamber antagonized by cell consumption, similar to the process in actual tumors (42).
We next asked whether waste products, and lactic acid in particular, accumulate within our assay. We measured the levels of relevant metabolites in the internal chamber and in the external chamber (Fig. 3D). Most measured metabolites did not show significant changes. However, the levels of lactate in the small internal chamber were more than fourfold higher than those in the external chamber (Fig. 3D; note that these are average values, and thus levels in ischemic regions are expected to be even higher). Visual inspection of any cell culture in our graded microenvironment chamber clearly reveals that pH gradients are formed because phenol red in the media gains a yellow hue in the deep interior regions, indicating low pH, while it retains its pink color near the slit. To assess this more rigorously, we measured spatial gradients of pH directly using BCECF, a widely used fluorescent ratiometric pH probe. After only 2 d of culture, clear pH gradients emerged in our graded microenvironment chamber (SI Appendix, Fig. S6). Taken together, these data show that the in vitro cellular system adequately models the gradients of resources, the accumulation of waste products, and the pH gradients that occur within tumors.
Emergence of Spatial Structure in Tumor/Macrophage Cocultures.
We cocultured MTLn3 cells and macrophages using our graded microenvironment system. Typically, an ∼105 cell homogenous mix of macrophages and MTLn3 cells at a 1:1 ratio was seeded. As expected, in cocultures with no gradients both cell types remained evenly distributed during the entire experiment (1 wk) (Fig. 4A). In sharp contrast, when diffusion was limited by the glass cover, spatial structure emerged in the cell population after a similar time (Fig. 4B). In well-perfused regions close to the slit, macrophages coexist with MTLn3 cells. However, in distal regions, the number of macrophages drops significantly relative to MTLn3 (Fig. 4B, P < 0.0001). Using the position of macrophages, we calculated macrophage density as a function of the distance from the slit (SI Appendix, Fig. S7 A and B). We found that macrophage density drops ∼10-fold in ischemic regions (SI Appendix, Fig. S7C). Although macrophages are affected the most, metabolic gradients additionally affect MTLn3 cells as their density also drops. In fact, high-cell-density clumps are visible in the culture without cover whereas in the graded condition there is high cell density only near the slit (Fig. 4A). We conducted the same experiment with two alternative cancer cell lines, H1650 or MDA-MB-231, also in coculture with macrophages. The experiments showed similar emergence of spatial structure (SI Appendix, Fig. S8A).
Our computational model predicts that lactic-acid–induced patterns occur even when glucose, and other nutrients, are not limiting. If this is correct, cocultures under nutrient gradients, but with uniformly low-lactic-acid levels, should not display spatial structure. To test this, we used a PDMS separation between the two chambers that, because of its oxygen permeability, will diminish lactic acid production (Fig. 1A). No spatial structure emerged under these conditions (SI Appendix, Fig. S7C), supporting that the hypoxic boost in lactic acid production is required for the emergence of spatial structure. Because macrophages are not directly affected by hypoxia (SI Appendix, Fig. S2A) but hypoxia can lead to high levels of lactic acid that are lethal for macrophages (Fig. 1 B and C), we conclude that metabolic alterations of the microenvironment cause macrophage death and the spontaneous emergence of tumor spatial structure.
Macrophage Death Due to Glycolytic Metabolism.
Macrophages also produce lactic acid, especially under hypoxia, but they do so at a much lower level than MTLn3 cells (five- to eightfold lower levels, Fig. 1A). Accordingly, macrophages cultured alone at the same initial density showed little or no spatial structure (SI Appendix, Fig. S8B). However, in theory, higher numbers of macrophages should produce enough lactate to reproduce the localization patterns. We therefore repeated the experiment, but this time seeding ∼106 macrophages (10× the previous cell density), and we were able to generate spatial structure in macrophage monocultures (SI Appendix, Fig. S8B). Macrophage disappearance was so extreme that virtually no macrophages could be found in ischemic regions (SI Appendix, Fig. S8C). These data support the conclusion that the spatial structure observed in cocultures is not caused by cancer cells specifically, but rather by the accumulation of metabolic waste products.
The patterns in our model can be explained by cell death (Fig. 2D). An alternative mechanism is that cells migrate from ischemic to well-perfused regions. To test this, we performed time-lapse imaging on cocultures within the graded microenvironment assay. We took advantage of the combination of high resolution and the wide field of tiling microscopy to track individual macrophages over a large area (∼5.4 × 0.65 mm). For quantitative analyses, we defined two regions of interest: the region comprising the first 2 mm proximal to the slit was designated as “Normal,” and the distal 2 mm of the image was designated as “Ischemic” (Fig. 4C). Initially the two cell types were distributed along the entire area but, after 72 h, macrophages were practically absent from the ischemic region (SI Appendix, Movie S2). More than 700 trajectories were analyzed. Only small but statistically significant differences in speed and persistence of normal versus ischemic macrophages were found (SI Appendix, Fig. S9 A and B). Nevertheless, there was no significant preference in the direction of migration that could explain the spatial structure observed in our experiments (Fig. 4C). More formally, the mean square displacement of either macrophage group was diffusive or subdiffusive, revealing no directional bias toward the slit (Fig. 4D). The calculated diffusivity constant for these cells was less than 2 μm2/min (1.7 ± 0.2 μm2/min in the highest case), which means that the cells would require times on the order of months to travel the distances in the millimeter scale required to explain the patterns. Thus, the role of cell migration in determining this spatial structure is negligible.
It is possible, then, that ischemic macrophages undergo a metabolic collapse due to high lactic acid, low glucose, hypoxia, etc. In fact, careful examination of the later frames in the time-lapse imaging movie shows that ischemic macrophages indeed slow down their movements, round up, and eventually disappear (SI Appendix, Movie S2). Cells typically round up in shape before dying (48). Accordingly, calculation of cell circularity shows that macrophages distal to the slit tend to be more circular than proximal ones (SI Appendix, Fig. S9C). To examine cell death more closely, we performed a time-lapse of a high-density macrophage culture with propidium iodide (PI) in the media to label nonviable cells (SI Appendix, Movie S3); PI is more adequate for time-lapse experiments (SI Appendix). As shown in Fig. 4E, the proportion of nonviable macrophages significantly increases over time but only for macrophages distant from the slit. Together, these results show that cell death, not migration, drives pattern formation because ischemic regions of the gradient assay are more toxic for macrophages than for MTLn3 cancer cells.
Role of Macrophage Recruitment in Spatial Structure.
Our measurements show that macrophage motility does not play a role in the emergence of spatial structure in the in vitro graded microenvironment. In vivo, however, macrophages can be activated and recruited to a tumor (22, 23, 32–34), and this active recruitment is likely to have an important role in TAM spatial structure. To test the role of TAM recruitment on spatial organization, we conducted 2D simulations of an expanding tumor with and without macrophage recruitment. We adapted the computational model to simulate an expanding tumor mass surrounded by well-irrigated stroma (SI Appendix, Fig. S10A) and simulated several scenarios by varying (i) the presence of macrophages in the initial tumor, (ii) the recruitment of macrophages to the tumor, and (iii) different values for the relative sensitivity of cancer cells and macrophages to an acidic environment. The simulations showed that macrophage recruitment can lead to spatial structure, but macrophage sensitivity to an ischemic environment can greatly enhance the effect (SI Appendix, Fig. S10 and Movie S4). To test the role of macrophage recruitment further, we conducted additional chamber experiments where macrophages were introduced in the chamber only after 48 h. Consistent with our model, macrophages could not colonize deep regions within the system (SI Appendix, Fig. S11), supporting that the ischemic environment plays a key role in spatial patterning even when macrophages arrive in the system at later stages of tumor development.
Discussion
Mathematical models of cancer have been developed for more than half a century, but only recently have oncologists recognized their value (49). Here we used a combination of mathematical modeling and in vitro experiment to show that cell metabolism can spontaneously create spatial heterogeneity in the extracellular milieu when perfusion is limited. Low-grade early tumors typically have TAMs, but these are homogenously spread throughout the tumor, showing no evident spatial structure. Spatial structure where TAMs are enriched at the edge of tumors is evident only in later, possibly more ischemic, tumors (SI Appendix, Fig. S4) (30). Our model provides a mechanistic explanation for these observations, suggesting that microenvironmental heterogeneities are key to establishing spatial patterns of localization of tumor-associated macrophages.
In addition to being at the edge of large tumors, TAMs can also be found in necrotic/anoxic regions from where they are proposed to promote angiogenesis (28). This is consistent with our experiments, as hypoxia per se does not kill macrophages (SI Appendix, Fig. S2A). Hypoxia and pH levels in tumors are not always correlated (15). Thus, we expect that TAMs in the necrotic core could survive in regions that, despite being hypoxic, have lower levels of lactic acid (50). Accordingly, in our experiments we have observed that macrophages can survive in hypoxic regions where there are fewer cancer cells.
Our model does not rule out additional mechanisms for spatial patterning of TAMs (22, 23, 32–34). Macrophages can infiltrate through tissues via para- or transcellular migration (51). However, it is not clear why infiltrating macrophages do not adopt a homogeneous distribution within tumors. Our results suggest one explanation: the same microenvironment that is lethal for macrophages in our culture should prevent infiltrating macrophages from colonizing deep regions of the tumor. Thus, the effect of metabolic alterations on the tumor microenvironment may synergize with other known mechanisms of macrophage localization.
We investigated spatial structuring of TAMs, which typically constitute the most prominent stromal cell population in tumors and often promote tumor progression (23, 24, 52, 53). Clinical evidence shows that the colocalization of carcinoma cells and macrophages near capillaries is correlated with metastasis in breast cancer (54). Thus, spatial structure may be a key element in tumor-promoting activities of TAMs. For example, localized invasion and entry of cancer cells into the bloodstream may be more effective when macrophages are not evenly distributed. Nonetheless, the metabolically altered microenvironments can have effects on stromal cells other than TAMs and, thus, may be a general mechanism for the emergence of spatial structure. For example, human cytotoxic T lymphocytes infiltrating lactic-acid–producing multicellular tumor spheroids have reduced cytokine production and proliferation, and low pH induces anergy (55, 56).
The intimate link between metabolism and intracellular processes, such as cell-signaling cascades and gene regulation, has revitalized tumor metabolism research (2–9). However, most studies focus on the intracellular mechanisms, and little attention has been paid to the extracellular consequences of cancer metabolism. We show here that tumor metabolic alterations can have a considerable impact on their microenvironment, leading to alterations of tumor-stromal spatial structure. If shown to be widespread, the modulation of cell metabolism and the extracellular milieu composition may open therapeutic possibilities. At the same time, they may force a rethinking of the microenvironmental consequences of current therapeutic strategies. For example, because ischemic regions can favor the emergent-resistant and aggressive clones (57, 58), therapies that target processes such as angiogenesis can lead to more and larger ischemic regions and potentially select for cancer lineages that are fitter than stromal cells.
Methods
Extraction and differentiation of BMDMs were performed according standard protocols (30). The graded microenvironment assay was created from glass-bottom glass dishes (Matek) based on a tissue mimetic assay (45). Microscopy was performed using an AxioObserver.Z1 (Zeiss), and images were analyzed with custom-made scripts in Matlab (MathWorks). For modeling details and complete methodology, please refer to SI Appendix.
Supplementary Material
Acknowledgments
We thank Catherine Konopacki, Inna Serganova, Grégoire Altan-Bonnet, Chris Sander, and the J.B.X. laboratory for helpful discussions and critical reading. We thank Inna Serganova for C6-HRE-GFP cells, Jeffrey Segall for MTLn3 cells, the Memorial Sloan–Kettering Cancer Center (MSKCC) metabolomics core facility for aid in measuring metabolites, and Joana Alves Vidigal for help in obtaining fresh MEFs. This work was supported by National Cancer Institute Grant CA148967 (to J.B.X. and J.A.J.) through the Integrative Cancer Biology Program and by the Office of the Director, National Institutes of Health, under Award DP2OD008440 (to J.B.X.). C.C.-F. is a Center for Cancer System Biology Independent Fellow. L.A. is supported by a MSKCC Brain Tumor Center fellowship.
Footnotes
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1311939110/-/DCSupplemental.
References
- 1.Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314. doi: 10.1126/science.123.3191.309. [DOI] [PubMed] [Google Scholar]
- 2.Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4(11):891–899. doi: 10.1038/nrc1478. [DOI] [PubMed] [Google Scholar]
- 3.DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7(1):11–20. doi: 10.1016/j.cmet.2007.10.002. [DOI] [PubMed] [Google Scholar]
- 4.Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi: 10.1126/science.1160809. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325–337. doi: 10.1038/nrc3038. [DOI] [PubMed] [Google Scholar]
- 6.Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11(2):85–95. doi: 10.1038/nrc2981. [DOI] [PubMed] [Google Scholar]
- 7.Lunt SY, Vander Heiden MG. Aerobic glycolysis: Meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27:441–464. doi: 10.1146/annurev-cellbio-092910-154237. [DOI] [PubMed] [Google Scholar]
- 8.Wellen KE, Thompson CB. A two-way street: Reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol. 2012;13(4):270–276. doi: 10.1038/nrm3305. [DOI] [PubMed] [Google Scholar]
- 9.Ward PS, Thompson CB. Metabolic reprogramming: A cancer hallmark even Warburg did not anticipate. Cancer Cell. 2012;21(3):297–308. doi: 10.1016/j.ccr.2012.02.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.San Martín A, et al. A genetically encoded FRET lactate sensor and its use to detect the Warburg effect in single cancer cells. PLoS ONE. 2013;8(2):e57712. doi: 10.1371/journal.pone.0057712. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Zhang J, Nuebel E, Daley GQ, Koehler CM, Teitell MA. Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal. Cell Stem Cell. 2012;11(5):589–595. doi: 10.1016/j.stem.2012.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Wang R, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011;35(6):871–882. doi: 10.1016/j.immuni.2011.09.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Mazurek S, Boschek CB, Hugo F, Eigenbrodt E. Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol. 2005;15(4):300–308. doi: 10.1016/j.semcancer.2005.04.009. [DOI] [PubMed] [Google Scholar]
- 14.Lee EY, et al. Hypoxia-enhanced wound-healing function of adipose-derived stem cells: Increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen. 2009;17(4):540–547. doi: 10.1111/j.1524-475X.2009.00499.x. [DOI] [PubMed] [Google Scholar]
- 15.Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation. Nat Med. 1997;3(2):177–182. doi: 10.1038/nm0297-177. [DOI] [PubMed] [Google Scholar]
- 16.Gatenby RA, et al. Cellular adaptations to hypoxia and acidosis during somatic evolution of breast cancer. Br J Cancer. 2007;97(5):646–653. doi: 10.1038/sj.bjc.6603922. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Nowell PC. The clonal evolution of tumor cell populations. Science. 1976;194(4260):23–28. doi: 10.1126/science.959840. [DOI] [PubMed] [Google Scholar]
- 18.Merlo LM, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary and ecological process. Nat Rev Cancer. 2006;6(12):924–935. doi: 10.1038/nrc2013. [DOI] [PubMed] [Google Scholar]
- 19.Gatenby RA, Gawlinski ET. A reaction-diffusion model of cancer invasion. Cancer Res. 1996;56(24):5745–5753. [PubMed] [Google Scholar]
- 20.Anderson AR, Weaver AM, Cummings PT, Quaranta V. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell. 2006;127(5):905–915. doi: 10.1016/j.cell.2006.09.042. [DOI] [PubMed] [Google Scholar]
- 21.Gatenby RA, Gillies RJ. A microenvironmental model of carcinogenesis. Nat Rev Cancer. 2008;8(1):56–61. doi: 10.1038/nrc2255. [DOI] [PubMed] [Google Scholar]
- 22.Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi: 10.1038/nature07205. [DOI] [PubMed] [Google Scholar]
- 23.Joyce JA, Pollard JW. Microenvironmental regulation of metastasis. Nat Rev Cancer. 2009;9(4):239–252. doi: 10.1038/nrc2618. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39–51. doi: 10.1016/j.cell.2010.03.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: Implications for new anticancer therapies. J Pathol. 2002;196(3):254–265. doi: 10.1002/path.1027. [DOI] [PubMed] [Google Scholar]
- 26.Zhang QW, et al. Prognostic significance of tumor-associated macrophages in solid tumor: A meta-analysis of the literature. PLoS ONE. 2012;7(12):e50946. doi: 10.1371/journal.pone.0050946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Cramer T, et al. HIF-1α is essential for myeloid cell-mediated inflammation. Cell. 2003;112(5):645–657. doi: 10.1016/s0092-8674(03)00154-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Murdoch C, Giannoudis A, Lewis CE. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood. 2004;104(8):2224–2234. doi: 10.1182/blood-2004-03-1109. [DOI] [PubMed] [Google Scholar]
- 29.White C, et al. Copper transport into the secretory pathway is regulated by oxygen in macrophages. J Cell Sci. 2009;122(Pt 9):1315–1321. doi: 10.1242/jcs.043216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Gocheva V, et al. IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev. 2010;24(3):241–255. doi: 10.1101/gad.1874010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Wyckoff JB, et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 2007;67(6):2649–2656. doi: 10.1158/0008-5472.CAN-06-1823. [DOI] [PubMed] [Google Scholar]
- 32.Ren G, et al. CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα. Cell Stem Cell. 2012;11(6):812–824. doi: 10.1016/j.stem.2012.08.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Gil-Bernabé AM, et al. Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. Blood. 2012;119(13):3164–3175. doi: 10.1182/blood-2011-08-376426. [DOI] [PubMed] [Google Scholar]
- 34.Ahn GO, et al. Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci USA. 2010;107(18):8363–8368. doi: 10.1073/pnas.0911378107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Goswami S, et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 2005;65(12):5278–5283. doi: 10.1158/0008-5472.CAN-04-1853. [DOI] [PubMed] [Google Scholar]
- 36.DeBerardinis RJ, et al. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA. 2007;104(49):19345–19350. doi: 10.1073/pnas.0709747104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Brizel DM, et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(2):349–353. doi: 10.1016/s0360-3016(01)01630-3. [DOI] [PubMed] [Google Scholar]
- 38.Walenta S, et al. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. Cancer Res. 2000;60(4):916–921. [PubMed] [Google Scholar]
- 39.Xavier JB, Picioreanu C, van Loosdrecht MCM. A framework for multidimensional modelling of activity and structure of multispecies biofilms. Environ Microbiol. 2005;7(8):1085–1103. doi: 10.1111/j.1462-2920.2005.00787.x. [DOI] [PubMed] [Google Scholar]
- 40.Nadell CD, Foster KR, Xavier JB. Emergence of spatial structure in cell groups and the evolution of cooperation. PLOS Comput Biol. 2010;6(3):e1000716. doi: 10.1371/journal.pcbi.1000716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Peirce SM, Van Gieson EJ, Skalak TC. Multicellular simulation predicts microvascular patterning and in silico tissue assembly. FASEB J. 2004;18(6):731–733. doi: 10.1096/fj.03-0933fje. [DOI] [PubMed] [Google Scholar]
- 42.Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 1955;9(4):539–549. doi: 10.1038/bjc.1955.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Swanson KR, et al. Quantifying the role of angiogenesis in malignant progression of gliomas: In silico modeling integrates imaging and histology. Cancer Res. 2011;71(24):7366–7375. doi: 10.1158/0008-5472.CAN-11-1399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Hawkins-Daarud A, Rockne RC, Anderson ARA, Swanson KR. Modeling tumor-associated edema in gliomas during anti-angiogenic therapy and its impact on imageable tumor. Front Oncol. 2013;3:66. doi: 10.3389/fonc.2013.00066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Cochran DM, Fukumura D, Ancukiewicz M, Carmeliet P, Jain RK. Evolution of oxygen and glucose concentration profiles in a tissue-mimetic culture system of embryonic stem cells. Ann Biomed Eng. 2006;34(8):1247–1258. doi: 10.1007/s10439-006-9134-4. [DOI] [PubMed] [Google Scholar]
- 46.Brader P, et al. Imaging of hypoxia-driven gene expression in an orthotopic liver tumor model. Mol Cancer Ther. 2007;6(11):2900–2908. doi: 10.1158/1535-7163.MCT-07-0432. [DOI] [PubMed] [Google Scholar]
- 47.Cox ME, Dunn B. Oxygen diffusion in poly(dimethyl siloxane) using fluorescence quenching. I. Measurement technique and analysis. J Polym Sci A Polym Chem. 1986;24:621–636. [Google Scholar]
- 48.Rello S, et al. Morphological criteria to distinguish cell death induced by apoptotic and necrotic treatments. Apoptosis. 2005;10(1):201–208. doi: 10.1007/s10495-005-6075-6. [DOI] [PubMed] [Google Scholar]
- 49.Rejniak KA, Anderson ARA. State of the art in computational modelling of cancer. Math Med Biol. 2012;29(1):1–2. doi: 10.1093/imammb/dqr029. [DOI] [PubMed] [Google Scholar]
- 50.Serganova I, et al. Metabolic imaging: A link between lactate dehydrogenase A, lactate, and tumor phenotype. Clin Cancer Res. 2011;17(19):6250–6261. doi: 10.1158/1078-0432.CCR-11-0397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol. 2007;7(9):678–689. doi: 10.1038/nri2156. [DOI] [PubMed] [Google Scholar]
- 52.Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L. The origin and function of tumor-associated macrophages. Immunol Today. 1992;13(7):265–270. doi: 10.1016/0167-5699(92)90008-U. [DOI] [PubMed] [Google Scholar]
- 53.Hanahan D, Coussens LM. Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell. 2012;21(3):309–322. doi: 10.1016/j.ccr.2012.02.022. [DOI] [PubMed] [Google Scholar]
- 54.Robinson BD, et al. Tumor microenvironment of metastasis in human breast carcinoma: A potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res. 2009;15(7):2433–2441. doi: 10.1158/1078-0432.CCR-08-2179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Fischer K, et al. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood. 2007;109(9):3812–3819. doi: 10.1182/blood-2006-07-035972. [DOI] [PubMed] [Google Scholar]
- 56.Calcinotto A, et al. Modulation of microenvironment acidity reverses anergy in human and murine tumor-infiltrating T lymphocytes. Cancer Res. 2012;72(11):2746–2756. doi: 10.1158/0008-5472.CAN-11-1272. [DOI] [PubMed] [Google Scholar]
- 57.Pàez-Ribes M, et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell. 2009;15(3):220–231. doi: 10.1016/j.ccr.2009.01.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Ebos JML, et al. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell. 2009;15(3):232–239. doi: 10.1016/j.ccr.2009.01.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.